Intrinsic Value of S&P & Nasdaq Contact Us

Aravive, Inc. ARAV NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
39/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$0.25
+523.4%

Aravive, Inc. (ARAV) has a consensus analyst rating of Hold, based on 18 analysts covering the stock. Of those, 8 recommend buying, 9 recommend holding, and 1 recommend selling.

The analyst consensus price target for ARAV is $0.25, representing a +523.4% upside from the current price of $0.0401. Price targets range from a low of $0.25 to a high of $0.25.

Analyst Consensus — ARAV

Hold
Strong Buy
0
Buy
8
Hold
9
Sell
1
Strong Sell
0
18 analysts
Price Targets
Consensus$0.25
High$0.25
Low$0.25
Median$0.25
Last Month Avg-
Last Quarter Avg-
Last Year Avg-
All-Time Count1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message